4.7 Article

Design and synthesis of unprecedented 9-and 10-membered cyclonucleosides with PRMT5 inhibitory activity

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Protein arginine methyltransferases: promising targets for cancer therapy

Jee Won Hwang et al.

Summary: This article discussed the roles of protein arginine methyltransferases (PRMTs) in cancer and their potential as targets in cancer therapy. Aberrant expression of PRMTs is closely related to cancer development, and PRMT inhibitors have shown promise in clinical trials.

EXPERIMENTAL AND MOLECULAR MEDICINE (2021)

Article Chemistry, Medicinal

The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer

Ryan Quiroz et al.

Summary: PRMT5 is a key enzyme involved in regulating various biological processes, and its dysregulation is linked to cancer development. Novel drug designs and synthetic methods have been developed for potent PRMT5 inhibitors, with efforts focused on balancing bioavailability and potency.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Organic

Development of a Flexible and Robust Synthesis of Tetrahydrofuro[3,4-b]furan Nucleoside Analogues

David A. Candito et al.

Summary: This study presents a flexible and robust strategy for accessing tetrahydrofuro[3,4-b]furan nucleoside analogues in the context of a PRMT5 inhibitor program. Compound 1.1-C was synthesized and demonstrated to be a potent PRMT5 inhibitor, laying the groundwork for the development of new inhibitors and nucleoside chemical matter for drug discovery programs.

JOURNAL OF ORGANIC CHEMISTRY (2021)

Article Immunology

PRMT5 Promotes Cyclin E1 and Cell Cycle Progression in CD4 Th1 Cells and Correlates With EAE Severity

Stephanie A. Amici et al.

Summary: This study found that PRMT5 promotes G1/S cell cycle progression and is associated with disease severity in an animal model of multiple sclerosis.

FRONTIERS IN IMMUNOLOGY (2021)

Review Chemistry, Multidisciplinary

Small rings in the bigger picture: ring expansion of three- and four-membered rings to access larger all-carbon cyclic systems

Bohdan Biletskyi et al.

Summary: In this review, the release of ring strain in cyclobutane and cyclopropane derivatives is highlighted as a way to rapidly increase molecular complexity. The state-of-the-art of ring expansions involving three- and four-membered cycles is discussed, with an emphasis on reaction types and mechanisms. Selected examples are used to illustrate the synthetic potential of this elegant synthetic tool.

CHEMICAL SOCIETY REVIEWS (2021)

Article Chemistry, Medicinal

A Chemical Probe for the Methyl Transferase PRMT5 with a Novel Binding Mode

Vineet Pande et al.

ACS MEDICINAL CHEMISTRY LETTERS (2020)

Review Chemistry, Medicinal

Nucleoside protein arginine methyltransferase 5 (PRMT5) inhibitors

Hong Lin et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)

Article Chemistry, Physical

OPLS3e: Extending Force Field Coverage for Drug-Like Small Molecules

Katarina Roos et al.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2019)

Article Chemistry, Medicinal

Discovery of Potent and Selective Covalent Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors

Hong Lin et al.

ACS MEDICINAL CHEMISTRY LETTERS (2019)

Article

PRMT5 prognostic value in cancer

Hanine Lattouf et al.

Oncotarget (2019)

Review Biochemistry & Molecular Biology

PRMT5 in gene regulation and hematologic malignancies

Fen Zhu et al.

GENES & DISEASES (2019)

Article Chemistry, Multidisciplinary

9-Membered Carbocycles: Strategies and Tactics for their Synthesis

Tatjana Huber et al.

CHEMISTRY-A EUROPEAN JOURNAL (2018)

Article Chemistry, Medicinal

Protein Arginine Methyltransferase 5 (PRMT5) as an Anticancer Target and Its Inhibitor Discovery

Yuanxiang Wang et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Chemistry, Medicinal

LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity

Zahid Q. Bonday et al.

ACS MEDICINAL CHEMISTRY LETTERS (2018)

Article Chemistry, Organic

Preparation of Both C5′ Epimers of 5′-C-Methyladenosine: Reagent Control Trumps Substrate Control

Cavan M. Bligh et al.

JOURNAL OF ORGANIC CHEMISTRY (2014)

Review Oncology

Protein arginine methyltransferases and cancer

Yanzhong Yang et al.

NATURE REVIEWS CANCER (2013)

Review Biochemistry & Molecular Biology

Recent Advances in Cyclonucleosides: C-Cyclonucleosides and Spore Photoproducts in Damaged DNA

Yuichi Yoshimura et al.

MOLECULES (2012)

Article Multidisciplinary Sciences

Crystal structure of the human PRMT5:MEP50 complex

Stephen Antonysamy et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Review Chemistry, Multidisciplinary

Purine 5 ',8-cyclonucleoside lesions: chemistry and biology

Chryssostomos Chatgilialoglu et al.

CHEMICAL SOCIETY REVIEWS (2011)

Review Chemistry, Multidisciplinary

Preparation of Cyclonucleosides

Adam Mieczkowski et al.

CHEMICAL REVIEWS (2010)

Review Biochemistry & Molecular Biology

Potential and Perspectives of Cyclonucleosides

A. Mieczkowski et al.

CURRENT MEDICINAL CHEMISTRY (2010)

Article Biochemistry & Molecular Biology

PRMT5 is required for cell-cycle progression and p53 tumor suppressor function

A. Scoumanne et al.

NUCLEIC ACIDS RESEARCH (2009)

Article Chemistry, Organic

Synthesis of cyclonucleosides having a C-C bridge

Christophe Len et al.

TETRAHEDRON (2008)

Article Chemistry, Organic

Synthesis and structure of novel cyclonucleoside analogues of uridine

Shi Zhong et al.

TETRAHEDRON (2008)

Article Plant Sciences

N3,5′-cycloxanthosine, the first natural occurrence of a cyclonucleoside

RJ Capon et al.

JOURNAL OF NATURAL PRODUCTS (2005)

Review Chemistry, Multidisciplinary

Synthesis of oxygen- and nitrogen-containing heterocycles by ring-closing metathesis

A Deiters et al.

CHEMICAL REVIEWS (2004)